NCT07497841

Brief Summary

This is a two-phase, non-randomized clinical trial conducted in eight communities in Miyun District, Beijing. The study first develops and validates a reliable 18-item questionnaire (Knowledge, Attitudes, and Practices \[KAP\] scale) to assess community residents' understanding, attitudes, and behaviors related to secondary hypertension. Then, we evaluate whether a 1-week community-centered short-video health education intervention (five 1-minute videos delivered via community WeChat groups by local physicians) can improve residents' secondary hypertension-related knowledge, attitudes, and practices. We will compare scores before and after the intervention, and analyze which groups (such as rural residents, people with lower education, older adults) benefit more. This study aims to provide a simple assessment tool and a scalable health education model for secondary hypertension in community settings, especially for rural and low-educated populations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,062

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

March 9, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

March 9, 2026

Last Update Submit

March 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in total score of the Secondary Hypertension Knowledge, Attitudes, and Practices (KAP) scale

    The total score of the validated 18-item KAP scale for secondary hypertension will be measured at baseline and post-intervention. The scale includes knowledge, attitudes, and practices dimensions using a 5-point Likert scale. A higher total score indicates better knowledge, more positive attitudes, and better practices related to secondary hypertension. The primary outcome is the mean change from baseline to post-intervention.

    Baseline (1 day before intervention) and within 24 hours after the 1-week intervention

Study Arms (1)

Community-Based Short-Video Intervention Group

EXPERIMENTAL

Participants received a one-week short-video intervention on secondary hypertension. Five one-minute videos covered definition, symptoms, screening, treatment, and prognosis. Videos were delivered via community WeChat groups. Community physicians monitored engagement. KAP scores were measured pre- and post-intervention.

Behavioral: Short-Video Health Education for Secondary Hypertension

Interventions

Participants received five one-minute educational videos about secondary hypertension via community WeChat groups over one week. Videos covered definition, symptoms, screening, treatment, and prognosis. Content was reviewed by specialists. Community physicians monitored engagement and sent reminders. The intervention aims to improve KAP levels.

Community-Based Short-Video Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Permanent residents aged ≥18 years with basic comprehension abilities, capable of completing the online questionnaire independently or with assistance
  • Voluntary participation and signed informed consent
  • For Phase 2 (Intervention Phase) only:
  • Individuals with confirmed hypertension or family members cohabiting with hypertensive patients
  • Member of a community WeChat group with the ability to receive and view short videos, and to complete online questionnaires independently or with assistance

You may not qualify if:

  • \- Cognitive impairment that would interfere with understanding the questionnaire or video content
  • Prior participation in standardized secondary hypertension public education programs
  • Inability to use WeChat or access short videos (for Phase 2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University First Hospital

Beijing, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2026

First Posted

March 27, 2026

Study Start

December 1, 2025

Primary Completion

January 31, 2026

Study Completion

March 1, 2026

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations